1-(1,3-Benzodioxol-5-Yl)-4,4-Dimethyl-1-Penten-3-Ol; 4,4-Dimethyl-1-(3,4-Methylenedioxyphenyl)-1-Penten-3-Ol; 4,4-Dimethyl-1-[3,4(Methylenedioxy)-Phenyl]-1-Penten-3-Ol,Diacomit; (E)-1-(1,3-Benzodioxol-5-Yl)-4,4-Dimethylpent-1-En-3-Ol; Diacomit; Bcx 2600

Brief Introduction

The action mechanism of stilamyl alcohol (slipantol) is unique. It can not only increase the release of GABA, but also inhibit the activity of some enzymes, so as to increase the blood concentration of other antiepileptic drugs. Stilamyl alcohol (slipantol) was approved in the EU in 2001 for adjuvant treatment of severe infantile epileptic myoclonic seizures.

[6-(Diethylaminomethyl)Naphthalen-2-Yl]Methyl N-[4-(Hydroxycarbamoyl)Phenyl]Carbamate

MSDS

CAS:497833-27-9

Molecular Formula:C24H27N3O4

Alias

More Information

Itf2357; (6-((Diethylamino)Methyl)Naphthalen-2-Yl)Methyl(4-(Hydroxycarbamoyl)Phenyl)Carbamate; Givinostat [Inn]; Ex-5958; Unii-5P60F84Fbh; Italfarmaco; Diethyl-[6-(4-Hydroxycarbamoyl-Phenylcarbamoyloxymethyl)-Naphthalen-2-Yl-Methyl]-Amine; Givinostat Free Base

Brief Introduction

Givinostat is an orally bioavailable hydroxymate inhibitor of histone deacetylase (HDAC) with potential anti-inflammatory, anti-angiogenic, and antineoplastic activities. Givinostat inhibits class I and class II HDACs, resulting in an accumulation of highly acetylated histones, followed by the induction of chromatin remodeling and an altered pattern of gene expression. At low, nonapoptotic concentrations, this agent inhibits the production of pro-inflammatory cytokines such as tumor necrosis factor- (TNF-), interleukin-1 (IL-1), IL-6 and interferon-gamma. Givinostat has also been shown to activate the intrinsic apoptotic pathway, inducing apoptosis in hepatoma cells and leukemic cells. This agent may also exhibit anti-angiogenic activity, inhibiting the production of angiogenic factors such as IL-6 and vascular endothelial cell growth factor (VEGF) by bone marrow stromal cells.

Proxymetacaine

MSDS

CAS:499-67-2

Molecular Formula:C16H26N2O3

Alias

More Information

Proparacaine; 2-(Diethylamino)Ethyl 3-Amino-4-Propoxybenzoate; Ophthaine; Proximetacainum; Alcaine

Brief Introduction

Proparacaine is a benzoic acid derivative anesthetic agent, with local anesthetic activity. Upon administration, proparacaine stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels. This inhibits the sodium ion influx required for the initiation and conduction of impulses within the neuronal cell, increases the threshold for electrical stimulation and results in a loss of sensation.

Thalidomide

MSDS

CAS:50-35-1

Molecular Formula:C13H10N2O4

Alias

More Information

Thalomid; 2-(2,6-Dioxopiperidin-3-Yl)Isoindoline-1,3-Dione; Sedoval; (+/-)-Thalidomide; N-Phthalylglutamic Acid Imide; 3-Phthalimidoglutarimide; Alpha-Phthalimidoglutarimide; (+-)-Thalidomide; 2,6-Dioxo-3-Phthalimidopiperidine; Thalidomide Celgene; Alpha-N-Phthalylglutaramide; N-(2,6-Dioxo-3-Piperidyl)Phthalimide; Glutarimide, 2-Phthalimido-; N-Phthalyl-Glutaminsaeure-Imid; Alpha-(N-Phthalimido)Glutarimide; 1H-Isoindole-1,3(2H)-Dione, 2-(2,6-Dioxo-3-Piperidinyl)-; 1,3-Dioxo-2-(2,6-Dioxopiperidin-3-Yl)Isoindoline; .Alpha.-N-Phthalylglutaramide; Phthalimide, N-(2,6-Dioxo-3-Piperidyl)-; 2-(2,6-Dioxopiperidin-3-Yl)-1H-Isoindole-1,3(2H)-Dione; 2-(2,6-Dioxopiperidin-3-Yl)-2,3-Dihydro-1H-Isoindole-1,3-Dione; .Alpha.-Phthalimidoglutarimide; 2-(2,6-Dioxo-3-Piperidinyl)-1H-Isoindole-1,3(2H)-Dione

Brief Introduction

Thalidomide is a synthetic glutamate derivative, which is mainly used to treat epilepsy. However, due to its lack of effectiveness, thalidomide was subsequently used as a sleep adjuvant and widely used to stop vomiting during pregnancy. In the early 1960s, thalidomide was reported to cause a large number of infant malformations, which was banned by many countries and withdrawn from the pharmaceutical market. However, scientists did not completely deny thalidomide and continued to conduct in-depth research on it, especially in immunization, anti-inflammatory Gratifying and encouraging results have been obtained in the pharmacology of anti angiogenesis and the clinical treatment of some difficult diseases, so that people have a new understanding of thalidomide.

Inquiry (

/ 10

)

Clear All